Key result
Continuous monitoring of left atrial pressures through implantable devices, particularly CardioMEMS, improves symptoms and decreases the rate of cardiac hospitalization in heart failure patients.
Why the study?
Do transcatheter implantable devices for monitoring left atrial pressures reduce heart failure hospitalizations in patients with chronic heart failure?
Do transcatheter implantable devices for monitoring left atrial pressures reduce heart failure hospitalizations in patients with chronic heart failure?
Continuous hemodynamic telemonitoring, particularly with pulmonary artery pressure sensors, is a promising strategy to dynamically optimize pharmacological therapy and prevent acute decompensation in chronic heart failure.
No takes yet. Share an insight, caveat, or question.
May support LA pressure monitoring to cut HF hospitalizations; leaves open need for confirmatory RCTs.
Rosa et al. (2017) conducted a review in Chronic heart failure. Transcatheter implantable devices for haemodynamic telemonitoring was evaluated. Continuous monitoring of left atrial pressures through implantable devices, particularly CardioMEMS, improves symptoms and decreases the rate of cardiac hospitalization in heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: